Sinusoidal Obstruction Syndrome Following Myeloablative Therapy and Tranexamic Acid Treatment for Hemorrhage in Two Patients with Neuroblastoma

Adverse thromboembolic events following administration of the anti-fibrinolytic agent tranexamic acid (TA), used to prevent/treat excessive blood loss, are rare. We present the clinical course of two young patients (22 and 56 months) receiving busulfan/melphalan (Bu/Mel) high-dose chemotherapy with...

Descripción completa

Detalles Bibliográficos
Autores principales: Zirngibl, Felix, Flemmig, Carina, Lang, Peter, Künkele, Annette, Eggert, Angelika, Schulte, Johannes H., Deubzer, Hedwig E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692027/
https://www.ncbi.nlm.nih.gov/pubmed/33126407
http://dx.doi.org/10.3390/children7110198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692027/
https://www.ncbi.nlm.nih.gov/pubmed/33126407
http://dx.doi.org/10.3390/children7110198

Ejemplares similares